Anebulo Pharmaceuticals I... (ANEB)
undefined
undefined%
At close: undefined
1.40
-3.11%
After-hours Dec 13, 2024, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 3.09M 11.25M 14.55M 19.99M 3.02M
Short-Term Investments - - - - -
Long-Term Investments - - - - -
Other Long-Term Assets 565.12K - - - -
Receivables - - - - 3.50K
Inventory - - - - -3.5
Other Current Assets 413.79K 422.75K 1.03M 1.67M -
Total Current Assets 3.51M 11.25M 14.55M 19.99M 3.03M
Property-Plant & Equipment - - - - -
Goodwill & Intangibles - - - - -
Total Long-Term Assets 565.12K - 1.03M 1.67M -
Total Assets 4.07M 11.67M 15.58M 21.65M 3.03M
Account Payables 156.43K 534.54K 380.83K 110.05K -
Deferred Revenue - - - - -
Short-Term Debt - - - - 201.29K
Other Current Liabilities 104.16K 534.26K 131.70K 131.59K 22.58K
Total Current Liabilities 260.58K 534.54K 512.53K 241.63K 223.87K
Long-Term Debt - - - - -
Other Long-Term Liabilities - - - - -
Total Long-Term Liabilities - 534.26K 380.83K 131.59K 2.98M
Total Liabilities 260.58K 1.07M 512.53K 241.63K 3.20M
Total Debt - - - - 201.29K
Common Stock 25.93K 25.63K 23.34K 23.34K 12.00K
Retained Earnings -65.40M -57.20M -45.47M -38.64M -183.14K
Comprehensive Income - 0.00 - -21.65M -2.99M
Shareholders Equity 3.81M 10.60M 15.07M 21.41M -171.14K
Total Investments - - - - -